DaVita Inc. (DVA)
NYSE: DVA · Real-Time Price · USD
117.17
-0.22 (-0.19%)
Dec 8, 2025, 2:47 PM EST - Market open
DaVita Revenue
DaVita had revenue of $3.42B in the quarter ending September 30, 2025, with 4.80% growth. This brings the company's revenue in the last twelve months to $13.32B, up 5.14% year-over-year. In the year 2024, DaVita had annual revenue of $12.82B with 5.56% growth.
Revenue (ttm)
$13.32B
Revenue Growth
+5.14%
P/S Ratio
0.68
Revenue / Employee
$175,236
Employees
76,000
Market Cap
8.27B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 12.82B | 675.40M | 5.56% |
| Dec 31, 2023 | 12.14B | 530.25M | 4.57% |
| Dec 31, 2022 | 11.61B | -8.90M | -0.08% |
| Dec 31, 2021 | 11.62B | 68.19M | 0.59% |
| Dec 31, 2020 | 11.55B | 162.13M | 1.42% |
| Dec 31, 2019 | 11.39B | -16.37M | -0.14% |
| Dec 31, 2018 | 11.40B | 528.22M | 4.86% |
| Dec 31, 2017 | 10.88B | 169.17M | 1.58% |
| Dec 31, 2016 | 10.71B | 725.22M | 7.27% |
| Dec 31, 2015 | 9.98B | -2.81B | -21.98% |
| Dec 31, 2014 | 12.80B | 1.03B | 8.76% |
| Dec 31, 2013 | 11.76B | 3.58B | 43.70% |
| Dec 31, 2012 | 8.19B | 1.45B | 21.61% |
| Dec 31, 2011 | 6.73B | 512.20M | 8.24% |
| Dec 31, 2010 | 6.22B | 118.96M | 1.95% |
| Dec 31, 2009 | 6.10B | 440.48M | 7.78% |
| Dec 31, 2008 | 5.66B | 396.02M | 7.52% |
| Dec 31, 2007 | 5.26B | 383.49M | 7.86% |
| Dec 31, 2006 | 4.88B | 1.91B | 64.12% |
| Dec 31, 2005 | 2.97B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
DVA News
- 5 days ago - DaVita: More Volatile But Better Upside Than Fresenius - Seeking Alpha
- 21 days ago - DaVita Inc. (DVA) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript - Seeking Alpha
- 23 days ago - DaVita Inc. to Participate in Fireside Chat with Wolfe Research - PRNewsWire
- 4 weeks ago - DaVita Marks 25 Years of Innovation with Breakthrough Kidney Care Research at ASN Kidney Week 2025 - PRNewsWire
- 5 weeks ago - DaVita Inc. (DVA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - DaVita misses quarterly profit estimates on rising costs, lower volumes - Reuters
- 5 weeks ago - DaVita Inc. 3rd Quarter 2025 Results - PRNewsWire
- 6 weeks ago - 3 Healthcare Stocks That Are Screaming Deals Right Now - The Motley Fool